900
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Improved spinal fusion efficacy by long-term delivery of bone morphogenetic protein-2 in a rabbit model

, , , , , , & show all
Pages 756-760 | Received 03 Mar 2010, Accepted 24 Jul 2011, Published online: 09 Nov 2011

  • Akamaru T, Suh D, Boden SD, Kim HS, Minamide A, Louis-Ugbo J. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine. 2003; 28 (5): 429-34.
  • Benglis D, Wang MY, Levi AD. A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery (Suppl 2) 2008; 62 (5):ONS423-31; discussion ONS31.
  • Boden SD, Schimandle JH, Hutton WC. Lumbar intertransverse-process spinal arthrodesis with use of a bovine bone-derived osteoinductive protein. J Bone Joint Surg (Am) 1995; 77 (9): 1404-17.
  • Burkus JK, Gornet MF, Dickman CA, Zdeblick TA. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002; 15 (5): 337-49.
  • Dimar JR, Glassman SD, Burkus KJ, Carreon LY. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 2006; 31 (22): 2534-9.
  • Hsu WK, Wang JC. The use of bone morphogenetic protein in spine fusion. Spine J 2008; 8 (3): 419-25.
  • Jeon O, Kang SW, Lim HW, Chung JH, Kim BS. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials 2006; 27 (8): 1598-607.
  • Jeon O, Song SJ, Kang SW, Putnam AJ, Kim BS. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. Biomaterials 2007; 28 (17): 2763-71.
  • Jeon O, Song SJ, Yang HS, Bhang SH, Kang SW, Sung MA, Lee JH, Kim BS. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Bioph Res Comm 2008; 369 (2): 774-80.
  • La WG, Kang SW, Yang HS, Bhang SH, Lee SH, Park JH, Kim BS. The efficacy of bone morphogenetic protein-2 depends on its mode of delivery. Artif Organs 2010; 34 (12): 1150-3.
  • Liao SS, Guan K, Cui FZ, Shi SS, Sun TS. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model. Spine 2003; 28 (17): 1954-60.
  • Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone - Biology and clinical applications. J Bone Joint Surg Am) 2002; 84 (6): 1032-44.
  • Minamide A, Kawakami M, Hashizume H, Sakata R, Tamaki T. Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine 2001; 26 (8): 933-9.
  • Petite H, Viateau V, Bensaid W, Meunier A, de Pollak C, Bourguignon M, Oudina K, Sedel L, Guillemin G. Tissue-engineered bone regeneration. Nat Biotechnol 2000; 18 (9): 959-63.
  • Ruhe PQ, Boerman OC, Russel F GM, Mikos AG, Spauwen P HM, Jansen JA. In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med 2006; 17 (10): 919-27.
  • Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, Hasegawa K, Ogamo A, Kamijo R. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem 2003; 278 (44): 43229-35.
  • Vaccaro AR, Whang PG, Patel T, Phillips FM, Anderson DG, Albert TJ, Hilibrand AS, Brower RS, Kurd MF, Appannagari A, Patel M, Fischgrund JS. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J 2008; 8 (3): 457-65.
  • Zhao BH, Katagiri T, Toyoda H, Takada T, Yanai T, Fukuda T, Chung UI, Koike T, Takaoka K, Kamijo R. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem 2006; 281 (32): 23246-53.